{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:57:06Z","timestamp":1788289026626,"version":"build-2803163510"},"reference-count":26,"publisher":"FapUNIFESP (SciELO)","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"abstract":"<jats:p>Abstract Alzheimer\u2019s disease (AD) is the most common cause of dementia. Despite numerous studies on the subject, the pathologies for AD are still unclear and there is still no ideal biomarker for diagnosis. The present study aimed to investigate clinical significance of human complement factor H (CFH) in patients with late-onset AD.  Methods:  The present prospective study included 187 late-onset AD patients who went to our hospital from January 2015 to December 2017. One hundred patients with mild cognitive impairment (MCI) and 80 healthy individuals who were age and gender matched to AD patients were enrolled as controls. Demographic data such as age, gender, and education duration were recorded. Blood samples were collected and serum levels of C-reactive protein (CRP), CFH, and brain-derived neurotrophic factor (BDNF) were determined by Enzyme-linked immunosorbent assay (ELISA). The mini-mental state examination (MMSE) score was measured for all patients.  Results:  No significant difference was found in age, gender, and education duration for all participants. The MMSE scores showed AD patients had lower MMES scores than the other two groups. All factors of CFH, CRP, and BDNF were dramatically decreased in AD patients compared with the MCI and the ealthy control. Levels of CFH were found to be positively correlated with levels of CRP; however, no significant correlation was found between CFH and BDNF, nor CFH and MMSE.  Conclusion:  CFH was decreased in late-onset AD patients, and serum levels of CFH was correlated with serum levels of CRP, but not MMSE and BDNF. These results may provide more clinical evidences for the role of CFH in AD patients.<\/jats:p>","DOI":"10.1590\/0004-282x20190151","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T09:31:10Z","timestamp":1580463070000},"page":"76-80","source":"Crossref","is-referenced-by-count":19,"title":["Complement factor H levels are decreased and correlated with serum C-reactive protein in late-onset Alzheimer's disease"],"prefix":"10.1590","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3365-4874","authenticated-orcid":false,"given":"Guo","family":"LU","sequence":"first","affiliation":[{"name":"Dezhou People's Hospital,  China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1102-6156","authenticated-orcid":false,"given":"Weihong","family":"LIU","sequence":"additional","affiliation":[{"name":"Dezhou People's Hospital,  China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9732-0136","authenticated-orcid":false,"given":"Xinying","family":"HUANG","sequence":"additional","affiliation":[{"name":"Dezhou People's Hospital,  China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4780-0550","authenticated-orcid":false,"given":"Yanxin","family":"ZHAO","sequence":"additional","affiliation":[{"name":"Jinan Central Hospital,  China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2020,2]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe DJ","year":"2016","journal-title":"EMBO Mol Med"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"455:532","DOI":"10.1016\/S1474-4422(16)00062-4","article-title":"Defeating Alzheimer's disease and other dementias: a priority for European science and society","volume":"15","author":"Winblad B","year":"2016","journal-title":"Lancet Neurol"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"229:36","DOI":"10.1038\/ni.3102","article-title":"Innate immunity in Alzheimer's disease","volume":"16","author":"Heneka MT","year":"2015","journal-title":"Nat Immunol"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2478\/s13380-013-0108-3","article-title":"The olfactory system in Alzheimer\u2019s disease: Pathology, pathophysiology and pathway for therapy","volume":"4","author":"Kov\u00e1cs T","year":"2013","journal-title":"Transl Neurosci"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/ana.10161","article-title":"Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study","volume":"51","author":"Riley KP","year":"2010","journal-title":"Ann Neurol"},{"issue":"7","key":"ref6","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","volume":"15","author":"Olsson B","year":"2016","journal-title":"Lancet Neurol"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.tips.2015.03.002","article-title":"Amyloid biomarkers in Alzheimer's disease","volume":"36","author":"Blennow K","year":"2015","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jneuroim.2009.08.013","article-title":"TNF-\u03b1 and antibodies to periodontal bacteria discriminate between Alzheimer\u2019s disease patients and normal subjects","volume":"216","author":"Kamer AR","year":"2009","journal-title":"J Neuroimmunol"},{"issue":"6","key":"ref9","first-page":"1122.e1","article-title":"The early events of Alzheimer's disease pathology: from mitochondrial dysfunction to BDNF axonal transport deficits","volume":"33","author":"Ye X","year":"2012","journal-title":"Neurobiol Aging"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"P387","DOI":"10.1016\/j.jalz.2009.04.1122","article-title":"Homocysteine, holotranscobalamin and risk of Alzheimer's disease: A longitudinal population-based study","volume":"5","author":"Hooshmand B","year":"2009","journal-title":"Alzheimers Dement"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.psychres.2014.08.059","article-title":"There are no differences in IL-6, CRP and homocystein concentrations between women whose mothers had AD and women whose mothers did not have AD","volume":"220","author":"Dev\u010di\u0107 S","year":"2014","journal-title":"Psychiatry Res"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1017\/S1461145710001008","article-title":"Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients","volume":"14","author":"Laske C","year":"2011","journal-title":"Int J Neuropsychoph"},{"issue":"14-15","key":"ref13","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.clinbiochem.2011.07.011","article-title":"C-reactive protein level is decreased in patients with Alzheimer's disease and related to cognitive function and survival time","volume":"44","author":"Nilsson K","year":"2011","journal-title":"Clin Biochem"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"193.e1","DOI":"10.1016\/j.ophtha.2006.10.004","article-title":"Complement factor H","volume":"114","author":"de la Fuente M","year":"2007","journal-title":"Ophthalmology"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molimm.2004.02.005","article-title":"The human complement factor H: functional roles, genetic variations and disease associations","volume":"41","author":"Rodr\u00edguez de C\u00f3rdoba S","year":"2004","journal-title":"Mol Immunol"},{"issue":"12","key":"ref16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/WNR.0b013e3283497334","article-title":"Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer's disease","volume":"22","author":"Alexandrov PN","year":"2011","journal-title":"Neuroreport"},{"key":"ref17","series-title":"Alzheimer's disease and age-related macular-degeneration: is complement factor H a common denominator?","author":"Williams MA","year":"2011"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3233\/JAD-142742","article-title":"Plasma Complement factor H in Alzheimer's Disease","volume":"45","author":"Williams MA","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"ref19","doi-asserted-by":"crossref","first-page":"613","DOI":"10.7150\/ijms.12742","article-title":"Relationship between the hs-CRP as non-specific biomarker and Alzheimer's disease according to aging process","volume":"12","author":"Song IU","year":"2015","journal-title":"Int J Med Sci"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neulet.2009.09.035","article-title":"Sialic acid, homocysteine and CRP: Potential markers for dementia","volume":"465","author":"Davis G","year":"2009","journal-title":"Neurosci Letters"},{"issue":"7","key":"ref21","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann G","year":"1984","journal-title":"Neurology"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12035-012-8234-4","article-title":"Regulation of Complement Factor H (CFH) by Multiple miRNAs in Alzheimer\u2019s Disease (AD) Brain","volume":"46","author":"Lukiw WJ","year":"2012","journal-title":"Mol Neurobiol"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"P303","DOI":"10.1016\/j.jalz.2012.05.826","article-title":"Chromosome 21-encoded miRNA-155 upregulation and complement factor H (CFH) deficits in Down syndrome (DS) and Alzheimer's disease (AD)","volume":"8","author":"Li YY","year":"2012","journal-title":"Alzheimers Dement"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.ajpath.2011.01.006","article-title":"Complement 3 and Factor H in Human Cerebrospinal Fluid in Parkinson's Disease, Alzheimer's Disease, and Multiple-System Atrophy","volume":"178","author":"Wang Y","year":"2011","journal-title":"Am J Pathol"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3233\/JAD-130497","article-title":"BDNF, TNF\u03b1, HSP90, CFH, and IL-10 serum levels in patients with early or late onset Alzheimer's disease or mild cognitive impairment","volume":"37","author":"Gezen-Ak D","year":"2013","journal-title":"J Alzheimers Dis"},{"issue":"1-2","key":"ref26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jns.2013.05.028","article-title":"Association of Plasma C-Reactive Protein Levels with Diagnosis of Alzheimer\u2019s Disease","volume":"333","author":"Yarchoan M","year":"2013","journal-title":"J Neurol Sci"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v78n2\/1678-4227-anp-0004-282x20190151.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T17:57:04Z","timestamp":1611424624000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2020000200076&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2]]}},"alternative-id":["S0004-282X2020000200076"],"URL":"https:\/\/doi.org\/10.1590\/0004-282x20190151","relation":{},"ISSN":["1678-4227","0004-282X"],"issn-type":[{"value":"1678-4227","type":"electronic"},{"value":"0004-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]}}}